Monocyte-to-Lymphocyte Ratio is a Significant Prognostic Factor for Patients With Non-Small Cell Lung Cancer Who Treated By Stereotactic Body Radiation Therapy: A Multi Institutional Study

被引：0
|
作者：
Tanaka, H. [1 ]
Ono, T. [1 ]
Takano, H. [1 ,2 ]
Manabe, Y. [1 ]
Kajima, M. [1 ]
Fujimoto, K. [1 ]
Yuasa, Y. [1 ]
Shiinoki, T. [1 ]
Yamaji, Y. [3 ]
Matsunaga, K. [3 ]
Matsuo, M. [4 ]
机构：
[1] Yamaguchi Univ, Grad Sch Med, Dept Radiat Oncol, Ube, Yamaguchi, Japan
[2] Gifu Univ, Grad Sch Med, Dept Radiol, Gifu, Japan
[3] Yamaguchi Univ, Grad Sch Med, Dept Respirol, Ube, Yamaguchi, Japan
[4] Gifu Univ, Dept Radiol, Gifu, Japan
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Y2939
引用
收藏
页码：E454 / E454
页数：1
相关论文
共 50 条
  • [1] Monocyte-to-lymphocyte ratio is a prognostic predictor for patients with non-small cell lung cancer treated with stereotactic body radiation therapy
    Tanaka, Hidekazu
    Ono, Taiki
    Kajima, Miki
    Manabe, Yuki
    Fujimoto, Koya
    Yuasa, Yuki
    Shiinoki, Takehiro
    Matsuo, Masayuki
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2024, 29 (02) : 228 - 235
  • [2] Monocyte-to-Lymphocyte Ratio Predicts the Response and Survival of Patients with Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
    Tanaka, H.
    Ono, T.
    Takano, H.
    Kajima, M.
    Manabe, Y.
    Shiinoki, T.
    Yamaji, Y.
    Matsunaga, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E140 - E140
  • [3] Anemia is a Significant Prognostic Factor in Overall Survival of Patients with Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
    Tanaka, H.
    Ono, T.
    Takano, H.
    Manabe, Y.
    Kajima, M.
    Shiinoki, T.
    Yamaji, Y.
    Matsunaga, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E152 - E153
  • [4] Lymphocyte Monocyte Ratio as a Prognostic Factor in Non-Small Cell Lung Cancer
    Yetisyigit, T.
    Seber, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1903 - S1904
  • [5] Comorbidity is a Prognostic Factor in Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy
    Chipidza, F. E.
    Franco, I.
    Chen, Y. H.
    Baldini, E. H.
    Chen, A. B.
    Kozono, D. E.
    Mak, R. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E677 - E677
  • [6] Anemia is a Prognostic Factor for Overall Survival Rate in Patients with Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
    Tanaka, Hidekazu
    Ono, Taiki
    Manabe, Yuki
    Kajima, Miki
    Fujimoto, Koya
    Yuasa, Yuki
    Shiinoki, Takehiro
    Yamaji, Yoshikazu
    Matsunaga, Kazuto
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7447 - 7453
  • [7] Anemia is a poor prognostic factor for stage I non-small cell lung cancer (NSCLC) patients treated with Stereotactic Body Radiation Therapy (SBRT)
    Pathak, Rima S.
    Pantarotto, Jason R.
    Cook, Graham
    Holmes, Oliver
    Cross, Peter
    MacRae, Robert M.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2019, 16 : 28 - 33
  • [8] Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy: An Analysis Focusing on Metastases
    Nonaka, H.
    Onishi, H.
    Chen, Z.
    Funayama, S.
    Watanabe, H.
    Komiyama, T.
    Marino, K.
    Aoki, S.
    Saito, R.
    Maehata, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E524 - E524
  • [9] Dynamic Neutrophil to Lymphocyte Ratio is a Useful Prognostic Factor in Locally Advanced Non-small Cell Lung Cancer Patients Treated with Thoracic Radiation Therapy: A Retrospective Study
    Dong, X.
    Wang, L.
    Bi, N.
    Zhou, Z.
    Xiao, Z.
    Feng, Q.
    Liang, J.
    Wang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E453 - E453
  • [10] Pre-treatment Neutrophil to Lymphocyte ratio (NLR) is a Prognostic Biomarker for Overall Survival in Localized Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
    Wu, T.
    Sebastian, N.
    Mo, X.
    Bazan, J. G.
    Welliver, M. X.
    Haglund, K. E.
    Williams, T. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E714 - E714
12345